Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Parcopa Preference in Parkinson's Disease
NCT00139867Phase 3Completed
- Sponsor
- UCB
- Start
- Jan 2004
- Primary completion
- May 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of levodopa in Parkinson's disease (PD), sponsored by UCB. Started Jan 2004; status: completed.
02
Drugs
levodopa
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00139867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00139867.